As ever, RANZCO’s poster area offered a glimpse into some of the work behind the scenes by the region’s ophthalmologists and clinical researchers, and included a healthy smattering from Aotearoa. Here are some that caught our eye.
- Queensland researchers investigating Rho-kinase inhibitor ripasudil (Glanatec) found it had a positive impact on preserving the cornea’s functional integrity following grafts, affirming previous findings. Noting a course of ripasudil treatment costs around a tenth of a corneal graft, Dr Yue-Ying Liu, from Princess Alexandra Hospital and Queensland Children’s Hospital, said the drug “offers a hopeful pharmacological and cost-saving option for handling deteriorating corneal transplants, potentially sparing patients additional endothelial graft procedures”.
- University of Auckland (UoA) PhD student Dr Tasleem Ahmad’s poster documented his results from a summer spent poring over 3,000 retinal images. Supervised by Dr Rachael Niederer, he evaluated indocyanine green angiography changes in uveitis patients, noting significant variation in hypofluorescent dark spots between different uveitis aetiologies.










